March 9th 2022
AS ONE CORPORATION
President:Takaji Iuchi
Security Code:7476
Contact:Keisuke Nishikawa Director
TEL: +81-6-6447-1210
February 2022 Operating Results (Flash Report)
1.Net Sales trends | Millions of yen | |||||||||||||
Apr. | May | Jun. | Jul. | Aug. | Sep. | |||||||||
FY03/2022 | 6,493 | 5,860 | 6,753 | 6,380 | 6,168 | 6,691 | ||||||||
FY03/2021 | 5,808 | 4,700 | 5,618 | 5,758 | 5,233 | 6,304 | ||||||||
FY03/2022 | +11.8% | +24.7% | +20.2% | +10.8% | +17.9% | +6.1% | ||||||||
% YoY | ||||||||||||||
Oct. | Nov. | Dec. | Jan. | Feb. | Mar. | |||||||||
FY03/2022 | 6,581 | 6,706 | 7,006 | 7,445 | 7,727 | |||||||||
FY03/2021 | 6,794 | 6,432 | 7,306 | 7,191 | 7,615 | 8,971 | ||||||||
FY03/2022 | (3.1)% | +4.3% | (4.1)% | +3.5% | +1.5% | |||||||||
% YoY | ||||||||||||||
2.Business day | ||||||||||||||
Apr. | May | Jun. | Jul. | Aug. | Sep. | Oct. | Nov. | Dec. | Jan. | Feb. | Mar. | |||
FY03/2022 | 21 | 18 | 22 | 20 | 19 | 20 | 21 | 20 | 20 | 18 | 18 | |||
YoY | ± 0 | ± 0 | ± 0 | ( 1) | + 1 | ± 0 | ( 1) | + 1 | ± 0 | ± 0 | ± 0 | |||
Sales per day | +11.8% | +24.7% | +20.2% | +16.3% | +11.7% | +6.1% | +1.5% | (1.0)% | (4.1)% | +3.5% | +1.5% | |||
% YoY* | ||||||||||||||
Note: AS ONE places particular emphasis on net sales per day, as sales of consumables used in research, industrial and medical fields tend to fluctuate according to variations in the total number of operating days.
3.Reference
Results for FYE 03/2022 are subject to residual YoY impact stemming from special environmental circumstances observed in FYE 03/2021, including special COVID-19-related demand. Accordingly, we suggest that you also refer to comparisons between results in FYE 03/2022 and FYE 03/2020.
Apr. | May | Jun. | Jul. | Aug. | Sep. | |
+31.4% | +19.4% | +36.5% | +14.6% | +32.9% | +17.0% | |
Vs. 3/2020 | Oct. | Nov. | Dec. | Jan. | Feb. | Mar. |
+27.5% | +30.4% | +28.3% | +29.3% | +19.7% |
About this material
The figures in these materials are non-consolidated figures that contain some provisional numbers from early reporting. They are provided to show trends for the convenience of investors. Temporarily uncategorized net sales, and adjustments for intra-Group transactions and deductions in consolidated financials are not accounted for. For purposes of reference, in fiscal year ended March 2021, the total annual net sales under this method were 77,729 million yen, annual net sales on a non-consolidated basis were 78,839 million yen, and consolidated net sales were 81,606 million yen.
The disclosure of this report in Jun., Sep., Dec. and Mar. will be made at the same time as the disclosure of the Summary of Financial Results.
1/4
Millions of yen・% | ||||||||||||||
Scientific sector | ||||||||||||||
5,000 | +80.0% | |||||||||||||
FY03/2021 | FY03/2022 | FY03/2021 | FY03/2022 | |||||||||||
% YoY | % YoY | |||||||||||||
4,500 | +70.0% | |||||||||||||
4,000 | +60.0% | |||||||||||||
3,500 | +50.0% | |||||||||||||
+41.8% | ||||||||||||||
3,000 | +40.0% | |||||||||||||
2,500 | +30.0% | |||||||||||||
+26.1% | ||||||||||||||
+20.2% | ||||||||||||||
+19.7% | ||||||||||||||
2,000 | +20.0% | |||||||||||||
+16.9% | +16.2% | |||||||||||||
+16.2% | +14.9% | |||||||||||||
+15.0% | +12.8% | +12.5% | +15.0% | |
+13.5% | +10.1% | +14.1% | ||
1,500 | +7.3% | +8.7% | ||
+3.3% | +5.1% | |||
+11.2% | +11.0% | |
+9.4% | +10.0% |
1,000 | +0.0% | ||||||||||||||
500 | (10.0)% | ||||||||||||||
(16.0)% | |||||||||||||||
0 | (20.0)% | ||||||||||||||
Apr. | May | Jun. | Jul. | Aug. | Sep. | Oct. | Nov. | Dec. | Jan. | Feb. | Mar. | ||||
Apr. | May | Jun. | Jul. | Aug. | Sep. | Oct. | Nov. | Dec. | Jan. | Feb. | Mar. | ||||
FY03/2020 | 2,594 | 2,683 | 2,785 | 3,081 | 2,548 | 3,187 | 2,889 | 2,918 | 3,178 | 3,391 | 3,771 | 4,375 | |||
FY03/2021 | 2,982 | 2,254 | 3,142 | 3,184 | 2,892 | 3,508 | 3,642 | 3,410 | 3,821 | 3,870 | 4,193 | 4,857 | |||
FY03/2022 | 3,465 | 3,197 | 3,762 | 3,584 | 3,324 | 3,764 | 3,827 | 3,923 | 4,152 | 4,498 | 4,587 | ||||
FY03/2021 | +15.0% | (16.0)% | +12.8% | +3.3% | +13.5% | +10.1% | +26.1% | +16.9% | +20.2% | +14.1% | +11.2% | +11.0% | |||
% YoY | |||||||||||||||
FY03/2022 | +16.2% | +41.8% | +19.7% | +12.5% | +14.9% | +7.3% | +5.1% | +15.0% | +8.7% | +16.2% | +9.4% | ||||
% YoY | |||||||||||||||
2/4
Millions of yen・% | ||||||||||
Industrial sector | ||||||||||
4,000 | +60.0% | |||||||||
FY03/2021 | FY03/2022 | FY03/2021 | FY03/2022 | |||||||
% YoY | % YoY | |||||||||
3,500 | +50.0% | |||||||||
3,000 | +40.0% | |
2,500 | +28.4% | +30.0% | |||||||||||
+21.7% | |||||||||||||
+19.8% | |||||||||||||
2,000 | +19.8% | +18.7% | +20.0% | ||||||||||
+8.9% | +10.5% | +9.1% | |||||||||||
1,500 | +10.0% | ||||||||||||
+7.5% | |||||||||||||
+6.0% | +6.0% | +4.0% | +4.2% | +4.1% |
+1.0% | +1.1% | +3.7% |
1,000 | (0.9)% | |
+2.5%
+1.3% |
+0.0%
(8.0)%
500 | (12.1)% | (13.9)% | (10.0)% | ||||||||||||
0 | (20.0)% | ||||||||||||||
Apr. | May | Jun. | Jul. | Aug. | Sep. | Oct. | Nov. | Dec. | Jan. | Feb. | Mar. | ||||
Apr. | May | Jun. | Jul. | Aug. | Sep. | Oct. | Nov. | Dec. | Jan. | Feb. | Mar. | ||||
FY03/2020 | 1,187 | 1,179 | 1,177 | 1,360 | 1,104 | 1,289 | 1,244 | 1,248 | 1,204 | 1,284 | 1,374 | 1,564 | |||
FY03/2021 | 1,277 | 1,037 | 1,189 | 1,171 | 1,015 | 1,278 | 1,355 | 1,301 | 1,429 | 1,332 | 1,409 | 1,706 | |||
FY03/2022 | 1,354 | 1,242 | 1,446 | 1,403 | 1,304 | 1,355 | 1,410 | 1,438 | 1,444 | 1,387 | 1,427 | ||||
FY03/2021 | +7.5% | (12.1)% | +1.0% | (13.9)% | (8.0)% | (0.9)% | +8.9% | +4.2% | +18.7% | +3.7% | +2.5% | +9.1% | |||
% YoY | |||||||||||||||
FY03/2022 | +6.0% | +19.8% | +21.7% | +19.8% | +28.4% | +6.0% | +4.0% | +10.5% | +1.1% | +4.1% | +1.3% | ||||
% YoY | |||||||||||||||
3/4
Millions of yen・% | |||||||||||
Hospital and Nursing | |||||||||||
4,000 | Care Sector | +96.0% | |||||||||
FY03/2021 | FY03/2022 | FY03/2021 | FY03/2022 | +90.9% | |||||||
% YoY | % YoY | +83.8% | |||||||||
3,500 | +80.0% | ||||||||||
+75.1% | +76.4% | ||||||||||
3,000+64.0%
+53.4% | ||||||||||||||||||||||||||||||
2,500 | +48.0% | |||||||||||||||||||||||||||||
+33.6% | +34.9% | +34.1% | +33.2% | |||||||||||||||||||||||||||
2,000 | +30.4% | +32.0% | ||||||||||||||||||||||||||||
+24.5% | +22.3% | |||||||||||||||||||||||||||||
+20.0% | ||||||||||||||||||||||||||||||
1,500 | +16.2% | +16.0% | ||||||||||||||||||||||||||||
+8.1% | ||||||||||||||||||||||||||||||
+3.6% | ||||||||||||||||||||||||||||||
+0.8% | ||||||||||||||||||||||||||||||
1,000 | (0.7)% | +0.0% | ||||||||||||||||||||||||||||
(14.9)% | ||||||||||||||||||||||||||||||
500 | (16.0)% | |||||||||||||||||||||||||||||
(21.8)% | (21.5)% | |||||||||||||||||||||||||||||
(25.2)% | ||||||||||||||||||||||||||||||
(31.4)% | ||||||||||||||||||||||||||||||
0 | (32.0)% | |||||||||||||||||||||||||||||
Apr. | May | Jun. | Jul. | Aug. | Sep. | Oct. | Nov. | Dec. | Jan. | Feb. | Mar. | |||||||||||||||||||
Apr. | May | Jun. | Jul. | Aug. | Sep. | Oct. | Nov. | Dec. | Jan. | Feb. | Mar. | |||||||||||||||||||
FY03/2020 | 1,159 | 1,045 | 987 | 1,127 | 989 | 1,241 | 1,026 | 976 | 1,077 | 1,082 | 1,313 | 1,807 | ||||||||||||||||||
FY03/2021 | 1,549 | 1,410 | 1,287 | 1,403 | 1,326 | 1,518 | 1,797 | 1,721 | 2,057 | 1,989 | 2,013 | 2,407 | ||||||||||||||||||
FY03/2022 | 1,674 | 1,421 | 1,544 | 1,393 | 1,540 | 1,572 | 1,344 | 1,346 | 1,410 | 1,560 | 1,713 | |||||||||||||||||||
FY03/2021 | +33.6% | +34.9% | +30.4% | +24.5% | +34.1% | +22.3% | +75.1% | +76.4% | +90.9% | +83.8% | +53.4% | +33.2% | ||||||||||||||||||
% YoY | ||||||||||||||||||||||||||||||
FY03/2022 | +8.1% | +0.8% | +20.0% | (0.7)% | +16.2% | +3.6% | (25.2)% | (21.8)% | (31.4)% | (21.5)% | (14.9)% | |||||||||||||||||||
% YoY | ||||||||||||||||||||||||||||||
Rapid growth in October of FYE 03/2021 was primarily due to
heavy impact from demand created associated with stringentCovid-19has begun to spread in Japan medical care conditions and recovery from a prior decline in
performance associated with a consumption tax increase implemented in October 2019.
4/4
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
As One Corporation published this content on 09 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 March 2022 06:30:14 UTC.